Role of Escitalopram Add-on in schizophrenia having subsyndromal depressive symptoms
- Conditions
- Health Condition 1: null- STABLE SCHIZOPHRENIA
- Registration Number
- CTRI/2018/01/011551
- Lead Sponsor
- Pooja Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 66
1)Patients aged between 18 to 50 years.
2)Availability of a reliable informant.
3)Written informed consent from the patient and/or informant.
4)Diagnosis of Schizophrenia as per ICD-10, DCR.
5)Satisfying operational definition of stable schizophrenia.
6)Having SSDs as defined for the purpose of this study
1)Patients having clinically significant medical disorder / disability or taking treatment for same.
2)Any comorbid psychiatric disorder other than nicotine dependence.
3)Patients already receiving antidepressants or mood stabilisers during last 8 weeks.
4)Patients who have received electroconvulsive therapy, other somatic treatments or any form of Psychotherapy during the last six months.
5)Any significant abnormality in routine investigations at baseline (Hb, TLC, DLC, RBS, S.Urea, S.Creatinine, LFT)
6)Pregnant and lactating females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS, HAM-D, SOFAS, SCoRSTimepoint: at 8 weeks
- Secondary Outcome Measures
Name Time Method PANSS, SOFAS, HAM-D, SCoRSTimepoint: 4 WEEKS